Dave Johnson is the founder of VelosBio. VelosBio has raised $213M in total funding. Latest round: Seed. Based in San Diego, CA.
David Johnson is a biopharmaceutical business leader with more than 25 years of experience in drug development. He is the founder and CEO of Solve Therapeutics, an oncology therapeutics company, and previously served as CEO of VelosBio until its acquisition by Merck. He has also held CEO positions at Acerta Pharma, which was acquired by AstraZeneca.
Full founder directory · Investor directory · Company funding database · Fundraising library